文献速递脊柱关节炎

全球银屑病关节炎患病率——系统综述与荟萃分析

The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

全球患病率为每10万成人112例,基于人群的研究估计为每10万成人113例,健康行政数据研究为每10万成人109例。各大洲间存在广泛差异,欧洲和北美患病率高于亚洲和南美洲。

要点

  • 全球银屑病关节炎患病率为每10万成人112例。
  • 基于人群的研究估计患病率为每10万成人113例,健康行政数据研究为每10万成人109例。
  • 欧洲和北美患病率高于亚洲和南美洲,但部分地理区域数据稀疏。

核心结论

  • 本综述将目前可获得的银屑病关节炎普通人群患病率估计汇总为全球和各大洲的估计值,并考虑了重要的研究设计特征。
  • 各大洲间存在广泛差异,部分地理区域数据稀疏,但现有证据提示银屑病关节炎在欧洲和北美比亚洲和南美洲更常见。
  • 当前最佳估计提示全球患病率为每10万成人112例。

研究设计与样本

  • 系统检索四个电子数据库,纳入报告银屑病关节炎患病率的研究,分别合并基于人群的研究和基于健康行政数据的研究。
  • 共纳入30项研究,其中15项来自欧洲。

主要发现

  • 全球银屑病关节炎患病率为每10万成人112例。
  • 基于人群的研究估计患病率为每10万成人113例,各大洲估计为欧洲每10万成人207例、北美每10万成人64例、亚洲每10万成人37例。
  • 健康行政数据研究给出的全球患病率为每10万成人109例,各大洲患病率为欧洲每10万成人175例、北美每10万成人147例、亚洲每10万成人78例、南美洲每10万成人17例。

局限性

  • 各大洲间存在广泛差异,部分地理区域数据稀疏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Previous attempts to pool prevalence studies in PsA have failed to take account of important methodological differences between studies that may have created biased estimates. The aim of this review is to estimate the prevalence of PsA within the adult general population worldwide, considering potential differences between population-based and health administrative studies separately. METHODS: Four electronic databases were systematically searched for articles reporting the prevalence of PsA. Data were pooled to generate worldwide prevalence estimates. Where sufficient data were available, results were summarized by continent. RESULTS: Thirty studies were identified, with half from Europe (n = 15). Thirteen population-based studies were identified comprising >92 000 adults, plus 17 studies (>180 million adults) based on health administrative data. The worldwide prevalence of PsA was 112 per 100 000 adults. The prevalence of PsA estimated using population-based studies was 113 per 100 000 with continent-specific estimates of 207 (Europe), 64 (North America) and 37 (Asia) per 100 000. Health administrative studies gave a global prevalence of 109 per 100 000 with continent-specific prevalence of 175 (Europe), 147 (North America), 78 (Asia) and 17 (South America). CONCLUSION: This review compiles currently available estimates of PsA prevalence in the general population into global and continent-based estimates and considers important study design characteristics. There is wide variability between continents, and data in some geographical areas are sparse, but available evidence suggests that PsA is more common in Europe and North America compared with Asia and South America, and current best estimates suggest a global prevalence of 112 per 100 000 adults.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lembke S, Macfarlane GJ, Jones GT, et al. The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis. Rheumatology (Oxford). 2024. PMID: 38530786. doi:10.1093/rheumatology/keae198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。